(Q34470170)

2 August 2017

title

Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats (English)

1 reference

2 August 2017

1 reference

Zaccheo T

1

1 reference

2 August 2017

Giudici D

series ordinal

2

1 reference

2 August 2017

di Salle E

series ordinal

3

1 reference

2 August 2017

language of work or name

1 reference

1 June 1998

1 reference

2 August 2017

1 reference

2 August 2017

volume

35

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

237-242

1 reference

Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Structural recognitions in the interactions of androgens and receptor proteins and in their association with nuclear acceptor components

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

17 beta-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5 alpha-reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Hormonal effects of turosteride, a 5 alpha-reductase inhibitor, in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Inhibitors of steroid 5 alpha-reductase in benign prostatic hyperplasia, male pattern baldness and acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

The clinical development of a 5α-reductase inhibitor, finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

The potential for hormonal prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Quantitative assessment of endogenous testicular and adrenal sex steroids and of steroid metabolizing enzymes in untreated human prostatic cancerous tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

Effect of castration, DES, flutamide, and the 5α-reductase inhibitor, MK-906, on the growth of the dunning rat prostatic carcinoma, R-3327

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980601%2935%3A4%3C237%3A%3AAID-PROS1%3E3.0.CO%3B2-D

10.1002/(SICI)1097-0045(19980601)35:4<237::AID-PROS1>3.0.CO;2-D

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference